Migraine is a common neurovascular sickness that is characterized by tender headaches and is commonly associated with other neurological indications, such as nausea, vomiting, and painful sensitivity to lights and sounds. Migraine is more common in women than men, majorly due to the fluctuations in the hormone levels. According to a Medline article, around 12% of the U.S. population suffers from migraine headaches. The treatment of migraine headaches is eased by administration of preventive medications, to avoid the migraine attacks and abortive medications to relieve the strong and periodic pain.
Migraine Market Segments:
The Global market is majorly segmented on the basis of types, treatment types and drug class. Based on the type, the Migraine market is segmented into episodic and chronic. Based on treatment types, the Migraine market classified into preventive and abortive. Further on the basis of drugs, the Migraine market is classified into triptans, ergots and others.
Key players :
The major players listed in the market research report include Allergan, Impax Laboratories, Abbott Laboratories, Inc., Eisai Inc., Eli Lilly and Company, Pfizer, Inc., Johnson & Johnson, Klaria, Kowa Pharmaceuticals America, Luitpold Pharmaceuticals, Meda, Merck, OptiNose, AstraZeneca plc, and GlaxoSmithKline plc.
Request Customization
Get a Sample
Get a Sample
Request Customization